GeneDx ups FY24 revenue view to $235M-$245M from $220M-$230M, consensus $226.1M
The Fly

GeneDx ups FY24 revenue view to $235M-$245M from $220M-$230M, consensus $226.1M

Raises FY24 adjusted gross margin profile view to at least 60% from at least 50%. Still expects to turn profitable in 2025.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App